Tirzepatide (Mounjaro)-induced acute pancreatitis and ketoacidosis in an adult nondiabetic patient
Tirzepatide (Mounjaro) is a new medication approved for type 2 diabetes and obesity treatment. It works by activating the receptors for both glucose-dependent insulinotropic peptide and glucagon-like peptide-1. Side effects due to tirzepatide are typically gastrointestinal in nature and self-resolvi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Saudi Journal for Health Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sjhs.sjhs_122_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|